CLB-1 Hormones and the Aging Brain

Program: Corporate Liaison Board Forum: Hormones and the Aging Brain
Clinical/Translational Session
Friday, March 6, 2015: 6:00 AM-8:00 AM
Sapphire D (Hilton San Diego Bayfront)
**This session is NOT eligible for CME credit**

This activity is supported by the Corporate Liaison Board of the Endocrine Society

Registration is required for this session:
There is no cost to attend; however, seating is limited. Complimentary breakfast will be provided and all ENDO attendees are welcome. Priority seating is given to Registration Ticket holders for the first 15 minutes after the advertised start time. If you have not been able to secure a Registration Ticket, the Endocrine Society will have a designated Non-Ticket holder line for general admission to the session on a first-come, first-served basis. While available seating cannot be guaranteed, the Endocrine Society will make every effort to accommodate you.

John Germak, MD, Novo Nordisk Inc, Princeton, NJ

Sponsored by the Corporate Liaison Board of the Endocrine Society, this yearly Forum highlights the collaboration between industry, academia, and health-care agencies, both government and non-government, in approaches to treatment of endocrine disorders.  Enhance your ENDO 2015 experience with this special breakfast symposium. Speakers representing clinical science and industry will provide perspectives on the regulation and function of hormones on the aging brain.

6:15 AM

John Germak, MD, Clinical Development, Medical and Regulatory Affairs, Novo Nordisk Inc., Plainsboro, NJ
Disclosure Not Provided: JG
6:25 AM

Walter A Rocca, MD, Health Sciences Research/Neurology, Mayo Clinic, Rochester, MN
Disclosure Not Provided: WAR
6:50 AM

Gail Musen, PhD, Clinical, Behavioral and Outcomes Research, Joslin Diabetes Center, Boston, MA
Disclosure Not Provided: GM
7:15 AM

Steven E. Arnold, MD, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA
Nothing to Disclose: SEA